It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 | Hyderabad, Telangana, India | ActivePerlin Pharmaceuticals Private Limited, a active private limited company, was established on 29 November 2019 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290TG2019PTC137238. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Satya Srinivas Tangella (Managing Director), Suryaprabha Anasuri (Director), Lalitha Akondi (Director). Past directors included Manikanta Peethani. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No-309, 3Rd Floor,Infocity Pearl Bhagyalaxmi Nagar, Sudharshan Nagar, Hyderabad, Telangana, 500019.
U24290TG2019PTC137238
137238
29 November 2019
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Perlin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satya Srinivas Tangella | Managing Director | 29 Nov 2019 | Current |
| Suryaprabha Anasuri | Director | 29 Nov 2019 | Current |
| Lalitha Akondi | Director | 29 Nov 2019 | Current |
| Girish Bathina | Director | 28 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Perlin Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Perlin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Perlin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Perlin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perlin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Perlin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Perlin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
Girish Bathina was appointed as a Director was appointed as a Director on 28 Jun 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
The activity Satya Srinivas Tangella was appointed as a Managing Director was appointed as a Managing Director on 29 Nov 2019 & has been associated with this company since 6 years 1 month . was completed.
Suryaprabha Anasuri was appointed as a Director was appointed as a Director on 29 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Lalitha Akondi was appointed as a Director was appointed as a Director on 29 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
The CIN of Perlin Pharmaceuticals Private Limited is U24290TG2019PTC137238.
Perlin Pharmaceuticals Private Limited is headquartered at Flat No-309, 3Rd Floor,Infocity Pearl Bhagyalaxmi Nagar, Sudharshan Nagar, Hyderabad, Telangana, 500019.
Perlin Pharmaceuticals Private Limited was incorporated on 29 November 2019.
The current directors of Perlin Pharmaceuticals Private Limited are
The primary industry of Perlin Pharmaceuticals Private Limited is Chemicals.
Perlin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Perlin Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX